Brief: Oncorus Reports Q4 2020 Results

Oncorus

10/03/2021 13:28

March 10 (Reuters) - Oncorus Inc  ONCR.O :
    * Q4 LOSS PER SHARE $0.56
    * EXPECTS TO HAVE SUFFICIENT CAPITAL TO FUND ITS OPERATING
EXPENSES AND CAPITAL EXPENDITURE REQUIREMENTS INTO LATE 2023
    * ONCORUS - ANTICIPATES CONTINUED GROWTH AND PROGRESS IN
2021
ACROSS ITS PIPELINE AND BUSINESS
    * ONCORUS - ANTICIPATES INITIAL INTERIM DATA READOUT OF
ONCR-177
PHASE 1 CLINICAL TRIAL IN SECOND HALF OF 2021

Source text for Eikon:  ID:nGNX5ntkwd 
Further company coverage:  ONCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))